Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zoo freezes genetic samples to save animals from extinction
Jaguars are among the threatened animal species that have been successfully cryopreserved in the Nature's SAFE biobank.
Chester Zoo partners with Nature's SAFE to cryopreserve threatened species. 

Conservationists at Chester Zoo have started to freeze tissue samples from some of the world's rarest creatures in a bid to save them from extinction.

The scientists have joined forces with leading animal reproduction experts to establish Nature's SAFE (Saving Animal From Extinction) – one of Europe's largest living biobanks for the future regeneration of animals. 

It involves taking ovarian and testicular tissue samples from deceased animals, and keeping them frozen at -196C, the point at which the cells enter a state of suspended animation.

The hope is that as reproductive technologies advance, the samples could help to further conserve species globally by generating sperm and eggs.

Nature's SAFE has already successfully cryopreserved multiple cell types from more than 100 highly threatened animal species, including the Eastern black rhino, mountain chicken frog, jaguar and Javan green magpie.

Dr Sue Walker, head of science at Chester Zoo and co-founder of Nature’s SAFE, explains: “With gene pools and animal populations continually shrinking in the wild, the work of modern conservation zoos like ours has never been more important. 

“Technologies, such as cryopreservation, offer us a new, critical piece of the conservation puzzle and helps us provide a safeguard for many of the world’s animals that, right now, we’re sadly on track to lose.” 

There are currently more than 142,500 species on The IUCN Red List, with more than 40,000 species threatened with extinction. Working closely with zoos across Europe, Nature's SAFE aims to provide a vital insurance policy for endangered wildlife to protect it for generations to come. 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.